1:30	The Molecular Characteristics of Aggressive B–cell Lymphomas - Riccardo Dalla-Favera, College of Physicians and Surgeons, Columbia University, New York, NY
2:00	Diffuse Large B–cell Lymphoma Outcome Prediction by Gene–Expression Profiling and Supervised Machine Learning - Margaret A. Shipp, Dana Farber Cancer Institute, Boston, MA
2:30	Morphologic and Immunophenotypic Correlations in the Diagnosis of Aggressive B–cell Lymphomas - Stefania Pittaluga, National Cancer Institute, NIH, Bethesda, MD
3:00	Recess
3:30	Transformation of Low Grade to Aggressive B–cell Lymphomas, Morphologic and Molecular Characteristics - Jonathan W. Said, UCLA School of Medicine, Los Angeles, CA
4:00	Burkitt and Burkitt–like Large Cell Lymphomas - Elaine S. Jaffe, National Cancer Institute, NIH, Bethesda, MD
4:30	Aggressive B–cell Lymphomas Associated with Immunosuppression - Amy Chadburn, New York Presbyterian Hospital, New York, NY